Table II.
Correlation between miR-222 expression and a variety of clinicopathological features of uterine cancer.
| Clinicopathological features | Cases | miR-222 expression | P-value |
|---|---|---|---|
| Age (years) | |||
| <40 | 17 | 0.394±0.074 | 0.916 |
| 40–60 | 21 | 0.371±0.068 | |
| >60 | 28 | 0.474±0.085 | |
| Tumor size (cm) | |||
| <4 | 27 | 0.527±0.093 | 0.617 |
| ≥4 | 39 | 0.416±0.078 | |
| Gross type | |||
| Exogenous type | 32 | 0.371±0.064 | 0.563 |
| Endogenous type | 19 | 0.398±0.069 | |
| Ulcer type | 11 | 0.474±0.086 | |
| Neck type | 4 | 0.973±0.184 | |
| Tissue differentiation | |||
| Large cell keratinizing (I) | 9 | 0.214±0.047 | 0.001 |
| Non-Keratinizing type (II) | 19 | 0.289±0.051 | |
| Small cell type (III) | 38 | 0.656±0.117 | |
| Pathological type | |||
| Squamous cell carcinoma | 53 | 0.427±0.082 | 0.628 |
| Adenocarcinoma | 9 | 0.416±0.079 | |
| Adenosquamous carcinoma | 4 | 0.398±0.077 | |
| FIGO stage | |||
| Stage I | 6 | 0.234±0.049 | 0.284 |
| Stage II | 25 | 0.425±0.082 | |
| Stage III | 18 | 0.419±0.084 | |
| Stage IV | 17 | 0.427±0.087 |